Neil S.

Neil S. possesses extensive experience in the pharmaceutical industry, currently serving as the Oncology Portfolio Strategic Advisor at Baxter International Inc. since May 2021. In addition, Neil holds a role as Consultant Medical Director at Zymeworks and has been the Chief Medical Officer at both Seneca Therapeutics, Inc. since April 2020 and SwanBio LLC since March 2014. This diverse background reflects a strong focus on strategic medical leadership within oncology and therapeutics.